TCTR20180125001尚未招募3 期
CARDIAC and LUNG dose reduction using DEEP INSPIRATION BREATH HOLD in left breast cancer irradiation (a dose comparison study based on CT image registration).
/A0 个研究点目标入组 80 人开始时间: 2018年1月25日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 N/A (No limit) 至 0 N/A (No limit)（—）
- 性别
- Female
入选标准
- •Left breast cancer who can do full inspiration.
排除标准
- •1 Major medical or psychiatric illness that would affect to the outcome, completion of therapy, the follow up and without potential in understand the side effects and risks of the therapy.
- •2 Hearing loss patient who can't command the deep inspiration instruction.
研究者
相似试验
已完成
不适用
Prospective Trial for heart dose reduction during radiotherapy in deep Inspiration breath-hold for left-sided breast cancer patientsC50D05Malignant neoplasm of breastCarcinoma in situ of breastDRKS00011213Klinikum Großhadern Klinik für Strahlentherapie und Radioonkologie600
招募中
3 期
Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced Chronic Kidney diseaseCTRI/2020/06/025708George Institute for Global Health
已完成
不适用
Coronary intervention dose reduction & image quality surveyCardiovascular: Coronary diseaseCirculatory SystemCoronary diseaseISRCTN96327158Record Provided by the NHSTCT Register - 2006 Update - Department of Health300
招募中
不适用
Concentration-guided dose reduction versus standard dosing in tocilizumab-treated rheumatoid arthritis patients: a randomised, international, multicenter, non-inferiority trial (TODORA)10003816Rheumatoid arthritisNL-OMON52409Jan van Breemen Instituut88
招募中
不适用
se of Tocilizumab Drug Levels to Optimize Treatment in RARheumatoid ArthritisNL-OMON20556Reade Rheumatology Research Institute98